查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1351107

2030 年临床试验包装市场预测：按细分市场和地区分類的全球分析

Clinical Trial Packaging Market Forecasts to 2030 - Global Analysis By Product Type, Clinical Trial Type, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球临床试验包装市场规模将达到30.4亿美元，预计在预测期内将以12.7%的年复合成长率成长，到2030年达到70.3亿美元。

临床试验产品使用临床试验包装解决方案进行包装、储存、保护和运输。进行临床试验来评估药物的有效性并确定各种药物製剂的最佳剂量。临床试验中使用多种产品，包括注射器、瓶子、泡罩、管子、安瓿和小瓶、袋子和小袋以及小袋。此外，这些产品需要特殊包装，因为标准包装会对临床试验结果产生负面影响，尤其是敏感药物。

根据美国消费品安全委员会的规定，我们可以选择的方案必须包括医生参与评估对个别患者的药物配发。

生技药品革命与个人化医疗

单株抗体、细胞疗法和基因疗法等生技药品的发展彻底改变了临床试验领域。为了保持稳定性和完整性，这些最先进治疗通常需要专门的包装解决方案。此外，由于个人化医疗（针对特定患者调整治疗方法），包装需求变得更加多样化。需要特殊的包装解决方案来适应不同的给药、配方和给药方法。

与永续性相关的环境议题

临床试验包装市场的一个主要障碍是对环境永续性的日益关注。为了减少对环境的影响，公司面临越来越大的压力，需要采取环保包装策略。此外，开发和实施这些环保包装方案的成本可能很高，即使符合全球环境目标，也会影响报酬率和营运费用。

数位科技的整合

临床试验包装透过整合数位技术提供了重要的机会。用于安全资料共用的区块链、用于改进可追溯性的二维码以及具有即时监控功能的物联网包装等创新正在彻底改变包装产业。此外，使用这些技术的包装公司可以透过减少错误和提高效率来改善其临床试验供应链。

原料成本上涨

临床试验包装市场不断受到塑胶、金属和特殊包装零件等原料价格波动的威胁。价格快速上涨会降低报酬率并影响整个包装解决方案的成本效益。此外，公司需要製定有效的筹资策略并密切监控原材料市场以减轻此威胁。这使您可以控製成本波动。

COVID-19 的影响：

临床试验包装市场受到 COVID-19大流行的严重影响。由于全球供应链和製造程序中断，包装供应的最初延误和短缺影响了临床试验的及时完成。此外，严格的封锁程序和旅行限制阻碍了临床试验材料的分发，造成后勤困难。然而，疫情也加速了整个产业的数位化配合措施，导致远端监控和智慧包装技术的采用。

预计瓶装领域在预测期内将是最大的市场

预计瓶装细分市场在预测期内将占据最大份额。各种类型的药品都包装在瓶子里，包括内服药物、液体药品，甚至是锭剂、胶囊等固态药品。该瓶子适应性强，易于使用，可满足各种储存和分配要求。此外，瓶子有多种尺寸和材料，使製药公司能够选择满足其产品特定需求的包装选项。

临床研究机构部门预计在预测期内年复合成长率最高

在临床试验包装市场中，临床研究机构细分市场在预测期内的年复合成长率最高。为了製药和生物技术公司的利益，CRO 对于进行临床试验至关重要。 CRO 管理大部分临床研究业务，包括病患招募、资料管理和法规合规性。此外，製药和生物技术公司越来越多地将临床试验业务委託给 CRO，以节省成本并获得专业知识，这推动了 CRO 的显着成长。临床试验数量的增加以及对临床试验包装服务需求的增加也促进了 CRO 领域的成长。

占比最高的地区

临床试验包装的最大市场占有率在北美，尤其美国。北美的优势在于其蓬勃发展的生物技术和製药行业、广泛的临床试验活动、完善的法规结构以及对研发的大量投资。此外，该地区先进的医疗保健系统和对创新的承诺使其成为临床试验包装的世界领导者。

复合年复合成长率最高的地区：

预计亚太地区的临床试验包装市场年复合成长率最高。该地区庞大且多样化的患者群体、快速成长的製药和生物技术产业以及医疗基础设施投资的增加要素了成长。此外，一些亚洲国家的製造和包装的可负担性增加了该地区作为临床试验包装服务来源的吸引力。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球临床试验包装市场：依产品类型

  • 注射器
  • 小瓶和安瓿
  • 瓶子
  • 袋/袋
  • 水疱
    • 冷成型
    • 热成型
  • 管子
  • 香囊
  • 套件或包
  • 其他产品类型

第6章全球临床试验包装市场：依临床试验类型

  • 治疗和预防
    • 疫苗
    • 药物研发发现与开发
    • 治疗设备
    • 生物相似药
    • 治疗测定
    • 治疗性治疗
  • 诊断
    • 诊断分析
    • 诊断设备
  • 其他临床试验类型

第7章全球临床试验包装市场：依材料分类

  • 塑胶
    • 聚氯乙烯（PVC）
    • 聚乙烯（PE）
      • 高密度聚苯乙烯（HDPE）
      • 低密度聚乙烯（LDPE）
    • 聚丙烯（PP）
  • 玻璃
  • 金属
  • 纸
  • 纸板
  • 其他材料

第8章全球临床试验包装市场：依最终使用者分类

  • 研究实验室
  • 临床研究组织
  • 药品生产设施
  • 製药公司
  • 生技公司
  • 学术研究所
  • 医院和诊所
  • 其他最终用户

第9章全球临床试验包装市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • PCI Pharma Services
  • Schreiner MediPharm
  • Berry Global, Inc.
  • 3M Company
  • Nupharm Group
  • Catalent, Inc.
  • Sharp Clinical Services, Inc.
  • Korber Medipak Systems AG
  • Parexel International Corporation
  • Alcami Corporation, Inc.
  • Reed-Lane, Inc.
  • Aphena Pharma Solutions
  • Symbiosis Pharmaceutical Services
  • Carton Service, Inc.
  • Piramal Pharma Solutions
  • Thermo Fisher Scientific Inc.
  • Xerimis Inc.
  • NextPharma Technologies Holding Limited
  • WestRock Company
  • Sentry BioPharma Services, Inc.
  • Yourway Transport Inc.
Product Code: SMRC23794

According to Stratistics MRC, the Global Clinical Trial Packaging Market is accounted for $3.04 billion in 2023 and is expected to reach $7.03 billion by 2030 growing at a CAGR of 12.7% during the forecast period. Clinical trial products are packaged, stored, protected, and transported using clinical trial packaging solutions. Clinical trials are conducted to evaluate a drug's effectiveness and determine the best dose for various pharmaceutical formulations. Clinical trials involve the use of a wide range of products, including syringes, bottles, blisters, tubes, ampoules and vials, bags and pouches, and sachets. Moreover, these products require special packaging because standard packaging has a negative impact on clinical trial outcomes, particularly for highly sensitive drugs.

According to CPSC, the options available to us must incorporate physician involvement in assessing dispensation of drug to individual patients.

Market Dynamics:

Driver:

Revolution in biologics and personalized medicine

With the development of biologics like monoclonal antibodies, cell therapies, and gene therapies, the field of clinical trials has undergone significant change. To maintain their stability and integrity, these cutting-edge therapies frequently need specialized packaging solutions. Additionally, the packaging requirements have become even more varied as a result of personalized medicine, which adapts treatments to specific patients. To accommodate various dosages, formulations, and administration techniques, specialized packaging solutions are required.

Restraint:

Environmental concerns with sustainability

A significant barrier to the market for clinical trial packaging is the increasing focus on environmental sustainability. In order to lessen their impact on the environment, businesses are under increasing pressure to adopt eco-friendly packaging strategies. Furthermore, the cost of developing and implementing these environmentally friendly packaging options may be higher, which will have an impact on profit margins and operating expenses even though they are in line with global environmental goals.

Opportunity:

Integration of digital technologies

Clinical trial packaging offers significant opportunities when digital technologies are incorporated. Innovations like blockchain for secure data sharing, QR codes for improved traceability, and IoT-enabled packaging with real-time monitoring capabilities are revolutionizing the packaging industry. Moreover, packaging companies that use these technologies can improve supply chains for clinical trials by doing so while lowering errors and increasing efficiency.

Threat:

Rising costs of raw materials

The clinical trial packaging market is constantly threatened by changes in the price of raw materials like plastics, metals, and specialty packaging components. Sudden price increases can reduce profit margins, which affects how cost-effective packaging solutions are overall. Additionally, companies need to establish effective procurement strategies and closely monitor the markets for raw materials to reduce this threat. This will help them control cost fluctuations.

COVID-19 Impact:

The clinical trial packaging market was significantly affected by the COVID-19 pandemic. Initial delays and shortages in packaging supplies had an impact on the timely completion of clinical trials due to disruptions in global supply chains and manufacturing procedures. Furthermore, the distribution of clinical trial materials was hampered by strict lockdown procedures and travel restrictions, creating logistical difficulties. But the pandemic also sped up industry wide efforts to transform digitally, leading to the adoption of remote monitoring and smart packaging technologies.

The Bottles segment is expected to be the largest during the forecast period

During the forecast period, it is anticipated that the bottle segment will hold the largest share. Many different types of medications, including oral medications, liquids, and even solid dosage forms like tablets and capsules, are packaged in bottles. They are adaptable, simple to use, and can accommodate various storage and dispensing requirements. Additionally, bottles are available in a range of sizes and materials, so pharmaceutical companies can select packaging options that meet the particular needs of their products.

The Clinical Research Organizations segment is expected to have the highest CAGR during the forecast period

In the market for clinical trial packaging, the clinical research organization segment is growing at the highest CAGR during the anticipated period. For the benefit of pharmaceutical and biotechnology companies, CROs are essential in carrying out clinical trials. They manage a sizable portion of clinical research tasks, such as patient recruitment, data management, and legal compliance. Furthermore, Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trial activities to CROs due to cost savings and specialized knowledge, which is fueling these companies' remarkable growth. The growing number of clinical trials and the increase in demand for clinical trial packaging services also contributed to the growth of the CRO segment.

Region with largest share:

The largest market share for clinical trial packaging was held by North America, particularly the United States. North America's dominance can be attributed to its thriving biotechnology and pharmaceutical industries, extensive clinical trial activities, well-established regulatory framework, and substantial investments in research and development. Moreover, this region leads the world in clinical trial packaging due to its sophisticated healthcare system and commitment to innovation.

Region with highest CAGR:

In the market for clinical trial packaging, the Asia-Pacific region is expected to have the highest CAGR. The region's large and diverse patient population and the burgeoning pharmaceutical and biotechnology industries were the main drivers of this growth, as were raising investments in healthcare infrastructure. Additionally, some Asian nation's affordable manufacturing and packaging options added to the region's appeal as a source of clinical trial packaging services.

Key players in the market:

Some of the key players in Clinical Trial Packaging market include: PCI Pharma Services, Schreiner MediPharm, Berry Global, Inc., 3M Company, Nupharm Group , Catalent, Inc. , Sharp Clinical Services, Inc. , Korber Medipak Systems AG, Parexel International Corporation , Alcami Corporation, Inc., Reed-Lane, Inc., Aphena Pharma Solutions, Symbiosis Pharmaceutical Services, Carton Service, Inc., Piramal Pharma Solutions , Thermo Fisher Scientific Inc., Xerimis Inc., NextPharma Technologies Holding Limited, WestRock Company, Sentry BioPharma Services, Inc. and Yourway Transport Inc.

Key Developments:

In May 2023, 3M today announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A., a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

In May 2023, Schreiner MediPharm has introduced a counterfeit and tampering protection solution whose void effect makes it exceedingly difficult for counterfeiters to successfully reuse original packaging. The company's tailored Void-Labels make previously covert messages readily visible upon peeling, making a package's first opening clearly and irreversibly apparent.

In April 2023, PCI Pharma Services (PCI), a leading global contract development and manufacturing organization announced that three new state-of-the-arts automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. The innovative machinery from Cytiva can be used to fill various sterile medications into vials and syringes for small-to-mid scale client needs.

Product Types Covered:

  • Syringes
  • Vials & Ampoules
  • Bottles
  • Bags & Pouches
  • Blisters
  • Tubes
  • Sachets
  • Kits or Packs
  • Other Product Types

Clinical Trial Types Covered:

  • Therapeutic and Prevention
  • Diagnostics
  • Other Clinical Trail Types

Materials Covered:

  • Plastic
  • Glass
  • Metal
  • Paper
  • Corrugated Fiber
  • Other Materials

End Users Covered:

  • Research Laboratories
  • Clinical Research Organizations
  • Drug Manufacturing Facilities
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Trial Packaging Market, By Product Type

  • 5.1 Introduction
  • 5.2 Syringes
  • 5.3 Vials & Ampoules
  • 5.4 Bottles
  • 5.5 Bags & Pouches
  • 5.6 Blisters
    • 5.6.1 Cold Forming
    • 5.6.2 Thermoforming
  • 5.7 Tubes
  • 5.8 Sachets
  • 5.9 Kits or Packs
  • 5.10 Other Product Types

6 Global Clinical Trial Packaging Market, By Clinical Trial Type

  • 6.1 Introduction
  • 6.2 Therapeutic and Prevention
    • 6.2.1 Vaccines
    • 6.2.2 Drug Discovery and Development
    • 6.2.3 Therapeutic Devices
    • 6.2.4 Biosimilars
    • 6.2.5 Therapeutic Assays
    • 6.2.6 Therapeutic Procedures
  • 6.3 Diagnostics
    • 6.3.1 Diagnostic Assay
    • 6.3.2 Diagnostic Devices
  • 6.4 Other Clinical Trail Types

7 Global Clinical Trial Packaging Market, By Material

  • 7.1 Introduction
  • 7.2 Plastic
    • 7.2.1 Polyvinyl Chloride (PVC)
    • 7.2.2 Polyethylene (PE)
      • 7.2.2.1 High Density Polyethylene (HDPE)
      • 7.2.2.2 Low Density Polyethylene (LDPE)
    • 7.2.3 Polypropylene (PP)
  • 7.3 Glass
  • 7.4 Metal
  • 7.5 Paper
  • 7.6 Corrugated Fiber
  • 7.7 Other Materials

8 Global Clinical Trial Packaging Market, By End User

  • 8.1 Introduction
  • 8.2 Research Laboratories
  • 8.3 Clinical Research Organizations
  • 8.4 Drug Manufacturing Facilities
  • 8.5 Pharmaceutical Companies
  • 8.6 Biotechnology Companies
  • 8.7 Academic & Research Institutes
  • 8.8 Hospitals & Clinics
  • 8.9 Other End Users

9 Global Clinical Trial Packaging Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 PCI Pharma Services
  • 11.2 Schreiner MediPharm
  • 11.3 Berry Global, Inc.
  • 11.4 3M Company
  • 11.5 Nupharm Group
  • 11.6 Catalent, Inc.
  • 11.7 Sharp Clinical Services, Inc.
  • 11.8 Korber Medipak Systems AG
  • 11.9 Parexel International Corporation
  • 11.10 Alcami Corporation, Inc.
  • 11.11 Reed-Lane, Inc.
  • 11.12 Aphena Pharma Solutions
  • 11.13 Symbiosis Pharmaceutical Services
  • 11.14 Carton Service, Inc.
  • 11.15 Piramal Pharma Solutions
  • 11.16 Thermo Fisher Scientific Inc.
  • 11.17 Xerimis Inc.
  • 11.18 NextPharma Technologies Holding Limited
  • 11.19 WestRock Company
  • 11.20 Sentry BioPharma Services, Inc.
  • 11.21 Yourway Transport Inc.

List of Tables

  • Table 1 Global Clinical Trial Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Trial Packaging Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Clinical Trial Packaging Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 4 Global Clinical Trial Packaging Market Outlook, By Vials & Ampoules (2021-2030) ($MN)
  • Table 5 Global Clinical Trial Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 6 Global Clinical Trial Packaging Market Outlook, By Bags & Pouches (2021-2030) ($MN)
  • Table 7 Global Clinical Trial Packaging Market Outlook, By Blisters (2021-2030) ($MN)
  • Table 8 Global Clinical Trial Packaging Market Outlook, By Cold Forming (2021-2030) ($MN)
  • Table 9 Global Clinical Trial Packaging Market Outlook, By Thermoforming (2021-2030) ($MN)
  • Table 10 Global Clinical Trial Packaging Market Outlook, By Tubes (2021-2030) ($MN)
  • Table 11 Global Clinical Trial Packaging Market Outlook, By Sachets (2021-2030) ($MN)
  • Table 12 Global Clinical Trial Packaging Market Outlook, By Kits or Packs (2021-2030) ($MN)
  • Table 13 Global Clinical Trial Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 14 Global Clinical Trial Packaging Market Outlook, By Clinical Trial Type (2021-2030) ($MN)
  • Table 15 Global Clinical Trial Packaging Market Outlook, By Therapeutic and Prevention (2021-2030) ($MN)
  • Table 16 Global Clinical Trial Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 17 Global Clinical Trial Packaging Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 18 Global Clinical Trial Packaging Market Outlook, By Therapeutic Devices (2021-2030) ($MN)
  • Table 19 Global Clinical Trial Packaging Market Outlook, By Biosimilars (2021-2030) ($MN)
  • Table 20 Global Clinical Trial Packaging Market Outlook, By Therapeutic Assays (2021-2030) ($MN)
  • Table 21 Global Clinical Trial Packaging Market Outlook, By Therapeutic Procedures (2021-2030) ($MN)
  • Table 22 Global Clinical Trial Packaging Market Outlook, By Diagnostics (2021-2030) ($MN)
  • Table 23 Global Clinical Trial Packaging Market Outlook, By Diagnostic Assay (2021-2030) ($MN)
  • Table 24 Global Clinical Trial Packaging Market Outlook, By Diagnostic Devices (2021-2030) ($MN)
  • Table 25 Global Clinical Trial Packaging Market Outlook, By Other Clinical Trail Types (2021-2030) ($MN)
  • Table 26 Global Clinical Trial Packaging Market Outlook, By Material (2021-2030) ($MN)
  • Table 27 Global Clinical Trial Packaging Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 28 Global Clinical Trial Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
  • Table 29 Global Clinical Trial Packaging Market Outlook, By Polyethylene (PE) (2021-2030) ($MN)
  • Table 30 Global Clinical Trial Packaging Market Outlook, By Polypropylene (PP) (2021-2030) ($MN)
  • Table 31 Global Clinical Trial Packaging Market Outlook, By Glass (2021-2030) ($MN)
  • Table 32 Global Clinical Trial Packaging Market Outlook, By Metal (2021-2030) ($MN)
  • Table 33 Global Clinical Trial Packaging Market Outlook, By Paper (2021-2030) ($MN)
  • Table 34 Global Clinical Trial Packaging Market Outlook, By Corrugated Fiber (2021-2030) ($MN)
  • Table 35 Global Clinical Trial Packaging Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 36 Global Clinical Trial Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 Global Clinical Trial Packaging Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 38 Global Clinical Trial Packaging Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 39 Global Clinical Trial Packaging Market Outlook, By Drug Manufacturing Facilities (2021-2030) ($MN)
  • Table 40 Global Clinical Trial Packaging Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 41 Global Clinical Trial Packaging Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 42 Global Clinical Trial Packaging Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 43 Global Clinical Trial Packaging Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 44 Global Clinical Trial Packaging Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.